Colorectal cancer association with metabolic syndrome and its components: A systematic review with meta-analysis

Endocrine

Volumn 44, Issue 3, 2013, Pages 634-647

  Esposito, Katherine ^a,c   Chiodini, Paolo ^a   Capuano, Annalisa ^a   Bellastella, Giuseppe ^a   Maiorino, Maria Ida ^a   Rafaniello, Concetta ^a   Panagiotakos, Demosthenes B ^b   Giugliano, Dario ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b HAROKOPIO UNIVERSITY   (Greece)

^c and Metabolic Diseases   (Italy)

Author keywords

Colorectal cancer; Incidence; Meta analysis; Metabolic syndrome; Mortality

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

BODY MASS; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER MORTALITY; CANCER RISK; COLORECTAL CANCER; DISEASE ASSOCIATION; DYSGLYCEMIA; HUMAN; HYPERTENSION; METABOLIC SYNDROME X; PRIORITY JOURNAL; PUBLICATION; REVIEW; RISK ASSESSMENT; SEX DIFFERENCE; SYSTEMATIC REVIEW; WAIST CIRCUMFERENCE;

COLORECTAL NEOPLASMS; COMORBIDITY; FEMALE; HUMANS; INCIDENCE; MALE; METABOLIC SYNDROME X; RISK; RISK FACTORS;

EID: 84890625084     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-013-9939-5     Document Type: Review

References (48)

1. American Cancer Society, Cancer facts & figures 2012 (American Cancer Society, Atlanta, 2012)
2. OECD. Health at a Glance 2011: OECD Indicators. OECD Publishing, http://dx.doi.org/10.1787/health-glance-2011-en. Accessed 27 Dec 2012
3. WHO Europe. Early detection of common cancer: colorectal cancer 2012, http://www.euro.who.int/en/what-we-do/health-topics/noncommunicable-diseases/ cancer/news/news/2012/2/early-detection-of-common-cancers. Accessed 27 Dec 2012
4. K.G. Alberti KG, R.H. Eckel RH, S.M. Grundy SM, P.Z. Zimmet PZ, J.I. Cleeman, et al. International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120, 1640-1645 (2009)
5. K. Esposito, P. Chiodini, A. Colao, A. Lenzi, D. Giugliano, Metabolic syndrome and risk of cancer: a systematic review and meta-analysis. Diabetes Care 35, 2402-2411 (2012)
6. R. Jinjuvadia, P. Lohia, C. Jinjuvadia, S. Montoya, S. Liangpunsakul, The association between metabolic syndrome and colorectal neoplasm: systemic review and meta-analysis. J Clin Gastroenterol 47, 33-44 (2013)
7. G. Wells, B. Shea, D. O'Connell, J. Peterson, V. Welch, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses, http://www.ohri.ca/programs/clinical-epidemiology/oxford.asp. Accessed 27 Dec 2012
8. A. Liberati, D.G. Altman, J. Tetzlaff, C. Mulrow, P.C. Gøtzsche et al., The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med 151, W65-W94 (2009)
9. S.L. Normand, Meta-analysis: formulating, evaluating, combining, and reporting. Stat Med 18, 321-329 (1999)
10. J.P. Higgins, S.G. Thompson, Quantifying heterogeneity in a meta-analysis. Stat Med 21, 1539-1558 (2002)
11. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285, 2486-2497 (2001)
12. H.C. van Houwelingen, L.R. Arends, T. Stijnen, Advanced methods in meta-analysis: multivariate approach and meta-regression. Stat Med 21, 589-624 (2002)
13. M. Egger, G. Davey Smith, M. Schneider, C. Minder, Bias in meta-analysis detected by a simple, graphical test. BMJ 315, 629-634 (1997)
14. M. Trevisan, J. Liu, P. Muti, G. Misciagna, A. Menotti et al., Markers of insulin resistance and colorectal cancer mortality. Cancer Epidemiol Biomarkers Prev 10, 937-941 (2001)
15. L.A. Colangelo, S.M. Gapstur, P.H. Gann, A.R. Dyer, K. Liu, Colorectal cancer mortality and factors related to the insulin resistance syndrome. Cancer Epidemiol Biomarkers Prev 11, 385-391 (2002)
16. R.L. AhmeL, K.H. Schmitz, K.E. Anderson, W.D. Rosamond, A.R. Folsom, The metabolic syndrome and risk of incident colorectal cancer. Cancer 107, 28-36 (2006)
17. K. Bowers, D. Albanes, P. Limburg, P. Pietinen, P.R. Taylor et al., A prospective study of anthropometric and clinical measurements associated with insulin resistance syndrome and colorectal cancer in male smokers. Am J Epidemiol 164, 652-664 (2006)
18. T. Stürmer, J.E. Buring, I.-M. Le, J.M. Gaziano, R.J. Glynn, Metabolic abnormalities and risk for colorectal cancer in the Physicians' Health Study. Cancer Epidemiol Biomarkers Prev 15, 2391-2397 (2006)
19. A. Russo, M. Autelitano, L. Bisanti, Metabolic syndrome and cancer risk. Eur J Cancer 44, 293-297 (2008)
20. T. Stocks, A. Lukanova, M. Johansson, S. Rinaldi, R. Palmqvist et al., Components of the metabolic syndrome and colorectal cancer risk; a prospective study. Int J Obes (Lond) 32, 304-314 (2008)
21. N. Kontou, T. Psaltopoulou, N. Soupos, E. Polychronopoulos, D. Xinopoulos et al., Metabolic syndrome and colorectal cancer: the protective role of Mediterranean diet - a case-control study. Angiology 63, 390-396 (2012)
22. M. Inoue, M. Noda, N. Kurahashi, M. Iwasaki, S. Sasazuki et al., Impact of metabolic factors on subsequent cancer risk: results from a large-scale population-based cohort study in Japan. Eur J Cancer Prev 18, 240-247 (2009)
23. C.E. Matthews, X. Sui, M.J. LaMonte, S.A. Adams, J.R. Hébert et al., Metabolic syndrome and risk of death from cancers of the digestive system. Metabolism 59, 1231-1239 (2010)
24. T. Stocks, A. Lukanova, T. Bjørge, H. Ulmer, J. Manjer et al., Metabolic factors and the risk of colorectal cancer in 580,000 men and women in the Metabolic Syndrome and Cancer Project (Me-Can). Cancer 117, 2398-2407 (2011)
25. Z. Shen, S. Wang, Y. Ye, M. Yin, X. Yang et al., Clinical study on the correlation between metabolic syndrome and colorectal carcinoma. ANZ J Surg 80, 331-336 (2010)
26. C. Pelucchi, E. Negri, R. Talamini, F. Levi, A. Giacosa et al., Metabolic syndrome is associated with colorectal cancer in men. Eur J Cancer 46, 1866-1872 (2010)
27. K. Aleksandrova, H. Boeing, M. Jenab, H. Bas Bueno-de-Mesquita, E. Jansen et al., Metabolic syndrome and risks of colon and rectal cancer: the European Prospective Investigation into Cancer and Nutrition Study. Cancer Prev Res (Phila) 4, 1873-1883 (2011)
28. G.C. Kabat, M.Y. Kim, U. Pete, M. Stefanick, L. Hou et al., A longitudinal study of the metabolic syndrome and risk of colorectal cancer in postmenopausal women. Eur J Cancer Prev 21, 326-332 (2012)
29. Y. Osaki, S.-I. Taniguchi, A. Tahara, M. Okamoto, T. Kishimoto, Metabolic syndrome and incidence of liver and breast cancers in Japan. Cancer Epidemiol 36, 141-147 (2012)
30. V. Ulaganathan, M. Kandiah, M.S. Zalilah, J.A. Faizal, H. Fijeraid et al., Colorectal cancer and its association with the metabolic syndrome: a Malaysian multi-centric case-control study. Asian J Cancer Prev 13, 3873-3877 (2012)
31. S.D. Hursting, M.J. Hursting, Growth signals, inflammation, and vascular perturbations: mechanistic links between obesity, metabolic syndrome, and cancer. Arterioscler Thromb Vasc Biol 32, 1766-1770 (2012)
32. G. Ho, T. Wang, M.J. Gunter, H.D. Strickler, M. Cushman et al., Adipokines linking obesity with colorectal cancer risk in postmenopausal women. Cancer Res 72, 3029-3037 (2012)
33. X.F. Huang, J.Z. Chen, Obesity, the PI3K/Akt signal pathway and colon cancer. Obes Rev 10, 610-616 (2009)
34. A.A. Moghaddam, M. Woodward, R. Huxley, Obesity and risk of colorectal cancer: a meta-analysis of 31 studies with 70000 events. Cancer Epidemiol Biomarkers Prev 16, 2533-2547 (2007)
35. E. Giovannucci, D. Michaud, The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas. Gastroenterology 132, 2208-2225 (2007)
36. T. Pischon, P.H. Lahmann, H. Boeing, C. Friedenreich, T. Norat et al., Body size and risk of colon and rectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC). J Natl Cancer Inst 98, 920-931 (2006)
37. J.Y. Park, P.N. Mitrou, R.H. Keogh, R.N. Luben, N.J. Wareham et al., Self-reported and measured anthropometric data and risk of colorectal cancer in the EPIC-Norfolk study. Intern J Obes 36, 107-118 (2012)
38. S.C. Larsson, N. Orsini, A. Wolk, Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst 97, 1679-1687 (2005)
39. H.U. Krämer, B. Schöttker, E. Raum, H. Brenner, Type 2 diabetes mellitus and colorectal cancer: meta-analysis on sex-specific differences. Eur J Cancer 48, 1269-1282 (2012)
40. S.H. Saydah, E.A. Platz, N. Rifai, M.N. Pollak, F.L. Brancati et al., Association of markers of insulin and glucose control with subsequent colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 12, 412-418 (2003)
41. M. Tsushima, A.M. Nomura, J. Lee, G.N. Stemmermann, Prospective study of the association of serum triglyceride and glucose with colorectal cancer. Dig Dis Sci 50, 499-505 (2005)
42. W. Borena, T. Stocks, H. Jonsson, S. Strohmaier, G. Nagel et al., Serum triglycerides and cancer risk in the metabolic syndrome and cancer (Me-Can) collaborative study. Cancer Causes Control 22, 291-299 (2011)
43. H. Ulmer, W. Borena, K. Rapp, J. Klenk, A. Strasak et al., Serum triglyceride concentrations and cancer risk in a large cohort study in Austria. Br J Cancer 101, 1202-1206 (2009)
44. F.J.B. van Duijnhoven, H.B. Bueno-De-Mesquita, M. Calligaro, M. Jenab, T. Pischon et al., Blood lipid and lipoprotein concentrations and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition. Gut 60, 1094-1102 (2011)
45. N.M. Maruthur, S. Bolen, K. Gudzune, F.L. Brancati, J.M. Clark, Body mass index and colon cancer screening: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev 21, 737-746 (2012)
46. L. Li, H.L. Huang, X.Y. Zhang, Z.H. LV, Association of metabolic syndrome and colorectal cancer. Zhonghua Wei Chang Wai Ke Za Zhi 14, 848-851 (2011)
47. K. Aleksandrova, H. Boeing, M. Jenab, H.B. Bueno-de-Mesquita, E. Jansen et al., Total and high-molecular weight adiponectin and risk of colorectal cancer: the European Prospective Investigation into Cancer and Nutrition Study. Carcinogenesis 33, 1211-1218 (2012)
48. K. Esposito, D. Giugliano, Lifestyle and adiponectin level: four-year follow-up of controlled trials. Arch. Intern. Med. 170, 1270-1271 (2010)